Oxidative stress-mediated downregulation of NO-cGMP-PKG signalling has been demonstrated in various experimental models of diabetes, insulin resistance, obesity and metabolic syndrome [1–4, 12, 14, 15]. Here, PRKG1 is linked to diabetes mellitus.